Copyright
©The Author(s) 2025.
World J Transplant. Jun 18, 2025; 15(2): 102507
Published online Jun 18, 2025. doi: 10.5500/wjt.v15.i2.102507
Published online Jun 18, 2025. doi: 10.5500/wjt.v15.i2.102507
Table 1 Summary of key prospective comparative studies and randomized controlled trials reporting the outcomes of endothelial keratoplasty procedures
Ref. | Publication | n | Study design | Indication | Intervention | Summary |
Stuart et al[46], 2016 | Cochrane Database of Systematic Reviews | 72 | Non-randomized, paired, contralateral-eye study | FECD and PBK | DMEK vs DSAEK | DMEK may provide better visual acuity than DSAEK for corneal endothelial failure, but with more graft dislocations |
Dunker et al[47], 2020 | Ophthalmology (Rochester, Minn) | 54 | Prospective, multicenter randomized controlled trial | FECD | DMEK vs UT-DSAEK | DMEK and UT-DSAEK corneal endothelial transplantation procedures have similar visual acuity and endothelial cell density outcomes |
Dickman et al[48], 2016 | Ophthalmology (Rochester, Minn) | 66 | Multicenter, prospective, double-masked, randomized, controlled clinical trial | FECD | UT-DSAEK vs DMEK | Ultrathin Descemet stripping automated endothelial keratoplasty (UT-DSAEK) results in faster and better visual acuity recovery compared to standard DSAEK |
Matsou et al[49], 2021 | Cornea | 56 | Prospective, double-blinded randomized controlled clinical trial | FECD | MT-DSAEK vs DMEK | DMEK surgery resulted in significantly better visual acuity compared to MT-DSAEK for treating Fuchs dystrophy-related corneal decompensation |
Chamberlain et al[50], 2019 | Ophthalmology (Rochester, Minn.) | 38 | Randomized, controlled, patient- and outcome-masked clinical trial | FECD and PBK | DMEK vs UT-DSAEK | DMEK had superior visual acuity results compared to UT-DSAEK for treating corneal endothelial dysfunction |
Shanmugam et al[51], 2023 | Cornea | 28 | Prospective, randomized, interventional study | Corneal Decom-pensation | PDEK vs DMEK | PDEK and DMEK procedures showed comparable visual and graft survival outcomes in endothelial decompensation |
Agarwal et al[52], 2017 | Canadian Journal of Ophthalmology | 6 | Prospective, single-centre, interventional case series | PBK | PDEK and DMEK | EK with epithelial debridement performed for the treatment of chronic PBK resulted in significantly improved visual acuity to a functional level, with the clearance of subepithelial fibrosis and anterior stromal scar, in most patients |
Table 2 Summary of comparative and non-comparative studies reporting the outcomes of corneal endothelial transplant procedures in various clinical scenarios
Ref. | Publication | Study design | Study duration | Study participants | Survival outcomes |
Fu et al[43], 2024 | Cornea | Retrospective clinical cohort study | 10 years | 356 (DSEK), Indication: 209 (FECD), 88 (bullous keratopathy), 39 (previous graft failure) | Overall, DSEK has a 79% 10-year graft survival rate (including complex grafts), with higher rates for Fuchs endothelial dystrophy (92%), despite significant endothelial cell loss |
Woo et al[53], 2019 | American Journal of Ophthalmology – Glaucoma | Retrospective comparative cohort study | 27 years | 121 eyes (DMEK), 423 eyes (DSAEK), 405 eyes (PK), for a total of 949 eyes from patients with FECD, and BK | DMEK (97.4%) has better long-term graft survival and lower complication rates compared to DSAEK (78.4%) and PK (54.6%) |
Price et al[54], 2011 | Ophthalmology (Rochester, Minn.) | Retrospective interventional case series | 5 years | 165 eyes (147) (89%)-FECD and 18 eyes (11%)-PBK and ABK] | Five-year graft survival and endothelial cell loss after Descemet's stripping endothelial keratoplasty are comparable to penetrating keratoplasty |
Birbal et al[55], 2020 | Cornea | Retrospective interventional case series | 5 years | 500 eyes of 393 patients. Indications: FECD, Bullous keratopathy, failed grafts | 5 Five-year graft survival probability in 0.90 with 82% achieving > 20/25 |
Deng et al[56], 2018 | Ophthalmology (Rochester, Minn.) | Systematic review | Follow-up ranged from 5.7 to 68 months | DMEK is a safe and effective treatment for corneal endothelial dysfunction, with better visual outcomes and lower refractive error compared to DSEK | |
Kang et al[57], 2019 | Journal of Glaucoma | Retrospective case series | Mean follow-up of 36.5 ± 31.4 months | 83 patients who underwent 122 DSEK procedures on 85 eyes | DSEK after glaucoma drainage device implantation has high graft failure rates and adverse effects on long-term graft survival |
Baydoun et al[58], 2015 | JAMA Ophthalmology | Retrospective cross-sectional studies | Approximately 9 years, from August 8, 2006 to June 17, 2015, with endothelial survival followed for up to 8 years after the DMEK procedures | 352 eyes, with 314 -FECD, 31 eyes-bullous keratopathy, and 7 eyes -failed previous endothelial grafts | Endothelial survival after Descemet membrane endothelial keratoplasty is better in eyes with Fuchs endothelial corneal dystrophy and completely attached grafts compared to eyes with bullous keratopathy and partially detached grafts |
Table 3 Comparison of outcomes of femtolaser-assisted endothelial keratoplasty procedures with conventional manual procedures
Ref. | Topic | Graft survival and graft-related complications | Visual Outcomes |
Malyugin et al[87], 2019 | FS-DSEK vs DSAEK | The graft survival was 89.5% in the femtosecond laser-assisted DSEK (FS-DSEK) group and 95% in the microkeratome-assisted DSAEK group, but the endothelial cell loss was higher in the FS-DSEK group compared to the DSAEK group at 12 months | The visual acuity outcomes were similar between the two groups at long-term follow-up |
Einan-Lifshitz et al[86], 2017 | FS-DMEK vs Manual DMEK (M-DMEK) | The graft survival, as indicated by the endothelial cell loss (24% vs 29%) and graft detachment rates (0% vs 20%), was better in the FE-DMEK group compared to the M-DMEK group | |
Sorkin et al[89], 2020 | F-DMEK and M-DMEK | Significantly lower rates of graft detachment (6.25% vs 35.6%) and need for rebubbling (6.25% vs 33.3%) in the F-DMEK group 3) Significantly lower rates of endothelial cell loss in the F-DMEK group at 1 and 2 years, 4) Numerically lower graft failure rate in the F-DMEK group (0% vs 8.9%), though not statistically significant | Comparable visual acuity improvement between F-DMEK and M-DMEK groups over 3 years |
Cheng et al[90], 2009 | FL-EK and PK | Mean postoperative BCVA was 20/70 ± 2 lines in the FLEK group and 20/44 ± 2 Lines in the PK group (P < 0.001), but the gain in the best corrected visual acuity between the two groups was not significantly different. The endothelial cell loss in the FL-EK and PK group was 65 ± 12% and 23 ± 15% (P < 0.001) | FL-EK reduces postoperative astigmatism but has higher endothelial cell loss compared to PK |
- Citation: Nishant P, Gurnani B, Singh P, Sinha S, Kaur K, Kumar A, Sinha RK. Current concepts and recent trends in endothelial keratoplasty. World J Transplant 2025; 15(2): 102507
- URL: https://www.wjgnet.com/2220-3230/full/v15/i2/102507.htm
- DOI: https://dx.doi.org/10.5500/wjt.v15.i2.102507